{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:47:03Z","timestamp":1788536823425,"version":"build-2803163510"},"reference-count":40,"publisher":"Tohoku University Medical Press","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2019]]},"DOI":"10.1620\/tjem.248.209","type":"journal-article","created":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T22:10:08Z","timestamp":1564524608000},"page":"209-216","source":"Crossref","is-referenced-by-count":10,"title":["Serum Soluble Interleukin-2 Receptor Is a Biomarker for &lt;i&gt;Pneumocystis jirovecii&lt;\/i&gt; Pneumonia among Patients with Rheumatoid Arthritis under Methotrexate Therapy"],"prefix":"10.1620","volume":"248","author":[{"given":"Noriho","family":"Sakamoto","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Hara","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences"},{"name":"Department of Respiratory Medicine, Aino Memorial Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ishimoto","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Yura","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuto","family":"Miyamura","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Okuno","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuko","family":"Hara","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Kakugawa","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Obase","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisako","family":"Kushima","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Fukuoka University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Fukuoka University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Noguchi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, School of Medicine, University of Occupational and Environmental Health, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kido","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, School of Medicine, University of Occupational and Environmental Health, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Sasebo Chuo Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Soejima","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Sasebo Chuo Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumako","family":"Yoshioka","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki Harbor Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Ishimatsu","sequence":"additional","affiliation":[{"name":"Department of Nursing, Nagasaki University Graduate School of Biomedical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Yatera","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, School of Medicine, University of Occupational and Environmental Health, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichi","family":"Kadota","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Infectious Diseases, Oita University Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Mukae","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Alanio, A. &amp; Bretagne, S. (2017)  Pneumocystis jirovecii detection in asymptomatic patients: what does its natural history tell us?  <i>F1000Res.<\/i>, 6, 739.","DOI":"10.12688\/f1000research.10619.1"},{"key":"2","unstructured":"Aletaha, D., Neogi, T., Silman, A.J., Funovits, J., Felson, D.T., Bingham, C.O. 3rd, Birnbaum, N.S., Burmester, G.R., Bykerk, V.P., Cohen, M.D., Combe, B., Costenbader, K.H., Dougados, M., Emery, P., Ferraccioli, G.,  et al. (2010)  2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative.  <i>Arthritis Rheum<\/i>., 62, 2569-2581."},{"key":"3","unstructured":"Chan, E.S. &amp; Cronstein, B.N. (2002)  Molecular action of methotrexate in inflammatory diseases.  <i>Arthritis Res<\/i>., 4, 266-273."},{"key":"4","unstructured":"Chodorowska, G., Czelej, D. &amp; Niewiedziol, M. (2003)  Interleukin-2 and its soluble receptor in selected drug-induced cutaneous reactions.  <i>Ann. Univ. Mariae Curie Sklodowska Med<\/i>., 58, 7-13."},{"key":"5","unstructured":"Genestier, L., Paillot, R., Fournel, S., Ferraro, C., Miossec, P. &amp; Revillard, J.P. (1998)  Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells.  <i>J. Clin. Invest<\/i>., 102, 322-328."},{"key":"6","doi-asserted-by":"crossref","unstructured":"Hara, S., Ishimoto, H., Sakamoto, N., Mukae, H., Kakugawa, T., Ishimatsu, Y., Mine, M. &amp; Kohno, S. (2011)  Direct hemoperfusion using immobilized polymyxin B in patients with rapidly progressive interstitial pneumonias: a retrospective study.  <i>Respiration; international review of thoracic diseases<\/i>, 81, 107-117.","DOI":"10.1159\/000321958"},{"key":"7","unstructured":"Hashimoto, A., Suto, S., Horie, K., Fukuda, H., Nogi, S., Iwata, K., Tsuno, H., Ogihara, H., Kawakami, M., Komiya, A., Furukawa, H., Matsui, T. &amp; Tohma, S. (2017)  Incidence and Risk Factors for Infections Requiring Hospitalization, Including Pneumocystis Pneumonia, in Japanese Patients with Rheumatoid Arthritis.  <i>Int. J. Rheumatol<\/i>., 2017, 6730812."},{"key":"8","doi-asserted-by":"crossref","unstructured":"Hori, S., Carvalho, T.L. &amp; Demengeot, J. (2002)  CD25+CD4+ regulatory T cells suppress CD4+ T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice.  <i>Eur. J. Immunol<\/i>., 32, 1282-1291.","DOI":"10.1002\/1521-4141(200205)32:5<1282::AID-IMMU1282>3.0.CO;2-#"},{"key":"9","unstructured":"Hoving, J.C. &amp; Kolls, J.K. (2017)  New advances in understanding the host immune response to Pneumocystis.  <i>Curr. Opin. Microbiol<\/i>., 40, 65-71."},{"key":"10","doi-asserted-by":"crossref","unstructured":"Johkoh, T., Muller, N.L., Colby, T.V., Ichikado, K., Taniguchi, H., Kondoh, Y., Fujimoto, K., Kinoshita, M., Arakawa, H., Yamada, H., Suga, M., Ando, M., Koyama, M. &amp; Nakamura, H. (2002)  Nonspecific interstitial pneumonia: correlation between thin-section CT findings and pathologic subgroups in 55 patients.  <i>Radiology<\/i>, 225, 199-204.","DOI":"10.1148\/radiol.2251011555"},{"key":"11","unstructured":"Kakugawa, T., Yokota, S., Ishimatsu, Y., Hayashi, T., Nakashima, S., Hara, S., Sakamoto, N., Matsuoka, Y., Kubota, H., Mine, M., Mukae, H., Nagata, K. &amp; Kohno, S. (2013)  Serum heat shock protein 47 levels in patients with drug-induced lung disease.  <i>Respir. Res<\/i>., 14, 133."},{"key":"12","unstructured":"Li, W.J., Guo, Y.L., Liu, T.J., Wang, K. &amp; Kong, J.L. (2015)  Diagnosis of pneumocystis pneumonia using serum (1-3)-beta-D-Glucan: a bivariate meta-analysis and systematic review.  <i>J. Thorac. Dis<\/i>., 7, 2214-2225."},{"key":"13","unstructured":"Limper, A.H., Offord, K.P., Smith, T.F. &amp; Martin, W.J. 2nd,  (1989)  Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS.  <i>Am. Rev. Respir. Dis<\/i>., 140, 1204-1209."},{"key":"14","doi-asserted-by":"crossref","unstructured":"Lopez-Olivo, M.A., Siddhanamatha, H.R., Shea, B., Tugwell, P., Wells, G.A. &amp; Suarez-Almazor, M.E. (2014)  Methotrexate for treating rheumatoid arthritis.  <i>Cochrane Database Syst. Rev.<\/i>, CD000957.","DOI":"10.1002\/14651858.CD000957.pub2"},{"key":"15","unstructured":"McKinley, L., Logar, A.J., McAllister, F., Zheng, M., Steele, C. &amp; Kolls, J.K. (2006)  Regulatory T cells dampen pulmonary inflammation and lung injury in an animal model of pneumocystis pneumonia.  <i>J. Immunol<\/i>., 177, 6215-6226."},{"key":"16","unstructured":"Mori, S., Cho, I. &amp; Sugimoto, M. (2009)  A followup study of asymptomatic carriers of Pneumocystis jiroveci during immunosuppressive therapy for rheumatoid arthritis.  <i>J. Rheumatol<\/i>., 36, 1600-1605."},{"key":"17","doi-asserted-by":"crossref","unstructured":"Norton, S., Koduri, G., Nikiphorou, E., Dixey, J., Williams, P. &amp; Young, A. (2013)  A study of baseline prevalence and cumulative incidence of comorbidity and extra-articular manifestations in RA and their impact on outcome.  <i>Rheumatology <\/i>(<i>Oxford<\/i>), 52, 99-110.","DOI":"10.1093\/rheumatology\/kes262"},{"key":"18","unstructured":"Polisson, R.P., Dooley, M.A., Dawson, D.V. &amp; Pisetsky, D.S. (1994)  Interleukin-2 receptor levels in the sera of rheumatoid arthritis patients treated with methotrexate.  <i>Arthritis Rheum<\/i>., 37, 50-56."},{"key":"19","doi-asserted-by":"crossref","unstructured":"Reddy, M.M. &amp; Grieco, M.H. (1988)  Elevated soluble interleukin-2 receptor levels in serum of human immunodeficiency virus infected populations.  <i>AIDS Res. Hum. Retroviruses<\/i>, 4, 115-120.","DOI":"10.1089\/aid.1988.4.115"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Richman, N.C., Yazdany, J., Graf, J., Chernitskiy, V. &amp; Imboden, J.B. (2013)  Extraarticular manifestations of rheumatoid arthritis in a multiethnic cohort of predominantly Hispanic and Asian patients.  <i>Medicine <\/i>(<i>Baltimore<\/i>), 92, 92-97.","DOI":"10.1097\/MD.0b013e318289ce01"},{"key":"21","unstructured":"Rubin, L.A. &amp; Nelson, D.L. (1990)  The soluble interleukin-2 receptor: biology, function, and clinical application.  <i>Ann. Intern. Med<\/i>., 113, 619-627."},{"key":"22","unstructured":"Rubin, L.A., Snow, K.M., Kurman, C.C., Nelson, D.L. &amp; Keystone, E.C. (1990)  Serial levels of soluble interleukin 2 receptor in the peripheral blood of patients with rheumatoid arthritis: correlations with disease activity.  <i>J. Rheumatol<\/i>., 17, 597-602."},{"key":"23","doi-asserted-by":"crossref","unstructured":"Shimada, K., Yokosuka, K., Nunokawa, T. &amp; Sugii, S. (2018)  Differences in clinical Pneumocystis pneumonia in rheumatoid arthritis and other connective tissue diseases suggesting a rheumatoid-specific interstitial lung injury spectrum.  <i>Clin. Rheumatol<\/i>., 37, 2269-2274.","DOI":"10.1007\/s10067-018-4157-4"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Silva, C.I. &amp; Muller, N.L. (2006)  Drug-induced lung diseases: most common reaction patterns and corresponding high-resolution CT manifestations.  <i>Semin. Ultrasound CT MR<\/i>, 27, 111-116.","DOI":"10.1053\/j.sult.2006.01.001"},{"key":"25","unstructured":"Singh, J.A., Saag, K.G., Bridges, S.L. Jr., Akl, E.A., Bannuru, R.R., Sullivan, M.C., Vaysbrot, E., McNaughton, C., Osani, M., Shmerling, R.H., Curtis, J.R., Furst, D.E., Parks, D., Kavanaugh, A., O\u2019Dell, J.,  et al. (2016)  2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.  <i>Arthritis Rheumatol<\/i>., 68, 1-26."},{"key":"26","doi-asserted-by":"crossref","unstructured":"Smolen, J.S., Landewe, R., Bijlsma, J., Burmester, G., Chatzidionysiou, K., Dougados, M., Nam, J., Ramiro, S., Voshaar, M., van Vollenhoven, R., Aletaha, D., Aringer, M., Boers, M., Buckley, C.D., Buttgereit, F.,  et al. (2017)  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease: modifying antirheumatic drugs: 2016 update.  <i>Ann. Rheum. Dis<\/i>., 76, 960-977.","DOI":"10.1136\/annrheumdis-2016-210715"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Song, Y., Ren, Y., Wang, X. &amp; Li, R. (2016)  Recent advances in the diagnosis of pneumocystis pneumonia.  <i>Med. Mycol. J<\/i>., 57, E111-E116.","DOI":"10.3314\/mmj.16-00019"},{"key":"28","unstructured":"Spadaro, A., Taccari, E., Riccieri, V., Sensi, F., Sili Scavalli, A. &amp; Zoppini, A. (1997)  Relationship of soluble interleukin-2-receptor and interleukin-6 with class-specific rheumatoid factors during low-dose methotrexate treatment in rheumatoid arthritis.  <i>Rev. Rhum. Engl. Ed<\/i>., 64, 89-94."},{"key":"29","doi-asserted-by":"crossref","unstructured":"Sumikawa, H., Johkoh, T., Ichikado, K., Taniguchi, H., Kondoh, Y., Fujimoto, K., Tateishi, U., Hiramatsu, T., Inoue, A., Natsag, J., Ikemoto, M., Mihara, N., Honda, O., Tomiyama, N., Hamada, S.,  et al. (2006)  Usual interstitial pneumonia and chronic idiopathic interstitial pneumonia: analysis of CT appearance in 92 patients.  <i>Radiology<\/i>, 241, 258-266.","DOI":"10.1148\/radiol.2411050928"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Takahashi, S., Setoguchi, Y., Nukiwa, T. &amp; Kira, S. (1991)  Soluble interleukin-2 receptor in sera of patients with pulmonary tuberculosis.  <i>Chest<\/i>, 99, 310-314.","DOI":"10.1378\/chest.99.2.310"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Tanaka, H., Narita, M., Teramoto, S., Saikai, T., Oashi, K., Igarashi, T. &amp; Abe, S. (2002)  Role of interleukin-18 and T-helper type 1 cytokines in the development of Mycoplasma pneumoniae pneumonia in adults.  <i>Chest<\/i>, 121, 1493-1497.","DOI":"10.1378\/chest.121.5.1493"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Tebib, J.G., Letroublon, M.C., Noel, E., Bienvenu, J. &amp; Bouvier, M. (1995)  sIL-2R levels in rheumatoid arthritis: poor correlation with clinical activity is due in part to disease duration.  <i>Br. J. Rheumatol<\/i>., 34, 1037-1040.","DOI":"10.1093\/rheumatology\/34.11.1037"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Thi Hong Nguyen, C., Kambe, N., Kishimoto, I., Ueda-Hayakawa, I. &amp; Okamoto, H. (2017)  Serum soluble interleukin-2 receptor level is more sensitive than angiotensin-converting enzyme or lysozyme for diagnosis of sarcoidosis and may be a marker of multiple organ involvement.  <i>J. Dermatol<\/i>., 44, 789-797.","DOI":"10.1111\/1346-8138.13792"},{"key":"34","unstructured":"Travis, W.D., Costabel, U., Hansell, D.M., King, T.E. Jr., Lynch, D.A., Nicholson, A.G., Ryerson, C.J., Ryu, J.H., Selman, M., Wells, A.U., Behr, J., Bouros, D., Brown, K.K., Colby, T.V., Collard, H.R.,  et al. (2013)  An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.  <i>Am. J. Respir. Crit. Care Med<\/i>., 188, 733-748."},{"key":"35","unstructured":"Turka, L.A. &amp; Walsh, P.T. (2008)  IL-2 signaling and CD4+ CD25+ Foxp3+ regulatory T cells.  <i>Front. Biosci<\/i>., 13, 1440-1446."},{"key":"36","unstructured":"Vorselaars, A.D., van Moorsel, C.H., Zanen, P., Ruven, H.J., Claessen, A.M., van Velzen-Blad, H. &amp; Grutters, J.C. (2015)  ACE and sIL-2R correlate with lung function improvement in sarcoidosis during methotrexate therapy.  <i>Respir. Med<\/i>., 109, 279-285."},{"key":"37","unstructured":"Wascher, T.C., Hermann, J., Brezinschek, H.P., Brezinschek, R., Wilders-Truschnig, M., Rainer, F. &amp; Krejs, G.J. (1994)  Cell-type specific response of peripheral blood lymphocytes to methotrexate in the treatment of rheumatoid arthritis.  <i>Clin. Investig<\/i>., 72, 535-540."},{"key":"38","unstructured":"Weinblatt, M.E., Trentham, D.E., Fraser, P.A., Holdsworth, D.E., Falchuk, K.R., Weissman, B.N. &amp; Coblyn, J.S. (1988)  Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis.  <i>Arthritis Rheum<\/i>., 31, 167-175."},{"key":"39","unstructured":"Witkowska, A.M. (2005)  On the role of sIL-2R measurements in rheumatoid arthritis and cancers.  <i>Mediators Inflamm<\/i>., 2005, 121-130."},{"key":"40","doi-asserted-by":"crossref","unstructured":"Zou, Y.Q., Li, Y.S., Ding, X.N. &amp; Ying, Z.H. (2012)  The clinical significance of HRCT in evaluation of patients with rheumatoid arthritis-associated interstitial lung disease: a report from China.  <i>Rheumatol. Int<\/i>., 32, 669-673.","DOI":"10.1007\/s00296-010-1665-1"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/248\/3\/248_209\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,3]],"date-time":"2019-08-03T03:45:56Z","timestamp":1564803956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/248\/3\/248_209\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.248.209","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}